Jane Street Group, LLC Organon & Co. Call Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2024 Feb 14, 2025	SELL	$14.44 - $18.83 $587,708 - $766,380	-40,700 Reduced 77.52%	11,800 $176,000
Q3 2024 Nov 14, 2024	BUY	$18.65 - $23.03 $979,124 - $1.21 Million	52,500 New	52,500 $1 Million
Q1 2022 May 17, 2022	BUY	$30.45 - $39.36 $654,370 - $845,846	21,490 Added 16.07%	155,200 $5.42 Million
Q4 2021 Feb 15, 2022	BUY	$28.67 - $37.13 $1.25 Million - $1.62 Million	43,740 Added 48.62%	133,710 $4.07 Million
Q3 2021 Nov 16, 2021	BUY	$28.63 - $35.64 $1.71 Million - $2.13 Million	59,890 Added 199.1%	89,970 $2.95 Million
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $855,776 - $1.14 Million	30,080 New	30,080 $910,000

813

201M

1.53M

1.07M

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.